Contineum Therapeutics, Inc. ($CTNM)
Filing Information
| Accession Number | 0001628280-26-046654 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 1, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
32,499
Total Value
$222,338.66
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CMO & Head of Development | Class A Common Stock | โ | Jun 30, 2026 | Exercise/Conversion | 10,833 | $4.50 | $48,748.50 | 19,794 | Direct | โ | View Details | |
CMO & Head of Development | Class A Common Stock | โ | Jun 30, 2026 | Sale | 10,833 | $16.02 | $173,590.16 | 8,961 | Direct | โ | View Details | |
CMO & Head of Development | Stock Option (right to buy) | Derivative | Jun 30, 2026 | Exercise/Conversion | 10,833 | $0.00 | $0.00 | 238,334 | Direct | โ | View Details |